Abstract
The identification of specific biomarkers for colorectal cancer would provide the basis for early diagnosis, prognosis, therapy, as well as clues for understanding the molecular mechanisms governing cancer progression. This study was designed to use comparative proteomics technology to find the differentially expressed proteins between human colorectal carcinoma and the corresponding normal tumor-adjacent colorectal tissues. We have used the highly sensitive two-dimensional gel electrophoresis (2-DE) coupled with matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF–MS) for the identification of proteins differentially expressed in tumoral and neighboring normal mucosa. We have detected differences in abundance of 42 proteins with statistical variance of the tumor versus normal spot volume ratio within the 95th confidence level (Student’s t-test; P < 0.05). 10 out of 42 analyzed proteins were unambiguously identified by MS coupled with database interrogation as being differentially expressed in colorectal cancer. Of the 10 newly implicated proteins, HSP27 was chosen for detailed analysis. Preliminary studies demonstrated that the differentially expressed proteins found by 2-DE could be confirmed and validated by western blotting and immunohistochemistry analyses in those few cases. The results suggest that HSP27 might be a potential biomarker for early diagnosis, prognosis, monitoring in the therapy of colorectal carcinoma.
Similar content being viewed by others
References
Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365:153–165
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ et al (2005) Cancer statistics. CA Cancer J Clin 55:10–30
Anderson L, Seilhamer J (1999) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533–537
Cole AR, Ji H, Simpson RJ (2000) Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53—null mice: a comparison with colonic polyps. Electrophoresis 21:1772–1781
Gordon JI, Smith DP, Alpers DH, Strauss AW (1982) Cloning of a cDNA encoding a portion of rat intestinal preapolipoprotein AIV mRNA. Biochemistry 21:5424–5431
Mazzanti R, Solazzo M, Fantappié O, Elfering S, Pantaleo P, Bechi P, Cianchi F et al (2006) Differential expression proteomics of human colon cancer. Am J Physiol Gastrointest Liver Physiol 290:G1329–G1338
Li C, Tan YX, Zhou H, Ding SJ, Li SJ, Ma DJ, Man XB et al (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 5:1125–1139
Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1:683–695
Li Z, Zhao X, Bai S, Wang Z, Chen L, Wei Y, Huang C (2008) Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 7:1810–1823
Herrmann PC, Liotta LA, Petricoin EF III (2001) Cancer proteomics: the state of the art. Dis Markers 17:49–57
Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M, Linehan WM et al. (2009) Pathway Biomarker Profiling of Localized and Metastatic Human Prostate Cancer Reveal metastatic and prognostic signatures. J Proteome Res Apr 24 [Epub ahead of print]
Byrne JC, Downes MR, O’Donoghue N, O’Keane C, O’Neill A, Fan Y, Fitzpatrick JM et al (2009) 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. J Proteome Res 8:942–957
Park HJ, Kim BG, Lee SJ, Heo SH, Kim JY, Kwon TH, Lee EB et al (2008) Proteomic profiling of endothelial cells in human lung cancer. J Proteome Res 7:1138–1150
Owling P, O’Driscoll L, Meleady P, Henry M, Roy S, Ballot J, Moriarty M et al (2007) 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis 28:4302–4310
Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z et al (2007) Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol Cell Proteomics 6:1798–1808
Leth-Larsen R, Lund R, Hansen HV, Laenkholm AV, Tarin D, Jensen ON, Ditzel HJ (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics Mar 24 [Epub ahead of print]
Huang HL, Stasyk T, Morandell S, Dieplinger H, Falkensammer G, Griesmacher A, Mogg M et al (2006) Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 27:1641–1650
Qi YJ, He QY, Ma YF, Du YW, Liu GC, Li YJ, Tsao GS et al (2008) Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. J Cell Biochem 104:1625–1635
Yoo C, Zhao J, Pal M, Hersberger K, Huber CG, Simeone DM, Beer DG, Lubman DM (2006) Automated integration of monolith-based protein separation with on-plate digestion for mass spectrometric analysis of esophageal adenocarcinoma human epithelial samples. Electrophoresis 27:3643–3651
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR et al (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5:e123
Hao Y, Yu Y, Wang L, Yan M, Ji J, Qu Y, Zhang J et al (2008) IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J Proteome Res 7:3668–3677
Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM et al (2006) Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 5:2092–2101
Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI (2005) Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5:2602–2611
Olesen SH, Christensen LL, Sørensen FB, Cabezón T, Laurberg S, Orntoft TF, Birkenkamp-Demtröder K (2005) Human FK506 binding protein 65 is associated with colorectal cancer. Mol Cell Proteomics 4:534–544
Rabilloud T (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2:3–10
Friedman DB, Hill S, Keller JW, Merchant NB, Levy SE, Coffey RJ, Caprioli RM (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4:793–811
Yu LR, Zeng R, Shao XX, Wang N, Xu YH, Xia QC (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21:3058–3068
Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21:3666–3672
Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J et al (2007) Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6:2495–2501
Zanini C, Pulerà F, Carta F, Giribaldi G, Mandili G, Maule MM, Forni M et al (2008) Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing’s sarcoma. Virchows Arch 452:157–167
Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM et al (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6:1049–1057
Langer R, Ott K, Specht K, Becker K, Lordick F, Burian M, Herrmann K et al (2008) Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin Cancer Res 15(14):8279–8287
Guo K, Kang NX, Li Y, Sun L, Gan L, Cui FJ, Gao MD et al (2009) Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 31(9):100
Doshi BM, Hightower LE, Lee J (2009) The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock. Cell Stress Chaperones Feb 18 [Epub ahead of print]
Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G, Theocharis SE (2009) Heat shock protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol 9(9):14
Xiao G, Lu Q, Li C, Wang W, Chen Y, Xiao Z (2009) Comparative proteome analysis of human adenocarcinoma. Med Oncol Apr 21. [Epub ahead of print]
Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A et al (2008) Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 7:1639–1650
Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME et al (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14:105–111
Merck KB, Groenen PJ, Voorter CE, de Haard-Hoekman WA, Horwitz J, Bloemendal H, de Jong WWJ (1993) Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein. A family of chaperones. Biol Chem 268:1046–1052
Kim KK, Kim R, Kim SH (1998) Crystal structure of a small heat-shock protein. Nature 394:595–599
Mosser DD, Morimoto RI (2004) Molecular chaperones and the stress of oncogenesis. Oncogene 23:2907–2918
Concannon CG, Gorman AM, Samali A (2003) On the role of Hsp27 in regulating apoptosis. Apoptosis 8:61–70
Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantôme A, Plenchette S et al (2003) HSP27 is a ubiquitin-binding protein involved in I-κBα proteasomal degradation. Mol Cell Biol 23:5790–5802
Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P et al (1998) Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 58:5495–5499
Melle C, Bogumil R, Ernst G, Schimmel B, Bleul A, von Eggeling F (2006) Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics 6:2600–2608
Acknowledgements
We would like to express our grateful to the staff in the Research center for Proteome analysis, Shanghai Institutes for biological sciences for technical assistance. This work was financially supported by the Grants from Shanghai Science and Technology Development Fund (No. 05DJ14010), the Major Basic Research Program of Shanghai (No. 07DZ19505), and the National 973 Basic Research Program of China (No. 2008CB517403).
Author information
Authors and Affiliations
Corresponding author
Additional information
Weijie Liu and Yanlei Ma contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liu, W., Ma, Y., Huang, L. et al. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep 37, 3207–3216 (2010). https://doi.org/10.1007/s11033-009-9903-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-009-9903-x